» Articles » PMID: 37863883

Multivariate Analyses of Immune Markers Reveal Increases in Plasma EN-RAGE in First-episode Psychosis Patients

Overview
Date 2023 Oct 20
PMID 37863883
Authors
Affiliations
Soon will be listed here.
Abstract

Immune cells and cytokines are largely recognized as significant factors in the pathophysiology of neuropsychiatric disorders. The possible role of other blood cells such as leukocytes in events of acute psychosis is in contrast only emerging. To study blood-born markers in acute psychosis we here evaluated plasma proteins in drug-naive first-episode psychosis (FEP) patients and healthy controls using a multiplex proximity extension assay technique. We analyzed a panel of 92 immune markers and plasma samples from 60 FEP patients and 50 controls and evaluated the changes obtained using multivariate statistical methods followed by protein pathway analyses. Data showed that 11 proteins are significantly different between FEP patients and healthy controls We observed increases in pro-inflammatory proteins such as interleukin-6, oncostatin-M, and transforming growth factor-alpha in FEP patients compared with controls. Likewise, the extracellular newly identified RAGE-binding protein (EN-RAGE) that regulates the expression of various cytokines was also elevated in the plasma of FEP patients. The results indicate that neutrophil-derived EN-RAGE could play an important role during the early phase of acute psychosis by stimulating cytokines and the immune response targeting thereby likely also the brain vasculature.

Citing Articles

Circulating Blood-Based Proteins in Psychopathology and Cognition: A Mendelian Randomization Study.

Bhattacharyya U, John J, Lam M, Fisher J, Sun B, Baird D JAMA Psychiatry. 2025; .

PMID: 40072421 PMC: 11904806. DOI: 10.1001/jamapsychiatry.2025.0033.


Predicting antipsychotic responsiveness using a machine learning classifier trained on plasma levels of inflammatory markers in schizophrenia.

Yee J, Phua S, See Y, Andiappan A, Goh W, Lee J Transl Psychiatry. 2025; 15(1):51.

PMID: 39952924 PMC: 11828904. DOI: 10.1038/s41398-025-03264-z.

References
1.
Upthegrove R, Manzanares-Teson N, Barnes N . Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res. 2014; 155(1-3):101-8. DOI: 10.1016/j.schres.2014.03.005. View

2.
Pillinger T, Osimo E, Brugger S, Mondelli V, McCutcheon R, Howes O . A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis. Schizophr Bull. 2018; 45(5):1120-1133. PMC: 6737479. DOI: 10.1093/schbul/sby160. View

3.
Muller N, Weidinger E, Leitner B, Schwarz M . The role of inflammation in schizophrenia. Front Neurosci. 2015; 9:372. PMC: 4612505. DOI: 10.3389/fnins.2015.00372. View

4.
Garcia-Bueno B, Bioque M, Mac-Dowell K, Fe Barcones M, Martinez-Cengotitabengoa M, Pina-Camacho L . Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull. 2013; 40(2):376-87. PMC: 3932081. DOI: 10.1093/schbul/sbt001. View

5.
Rehman R, Miller M, Krishnamurthy S, Kjell J, Elsayed L, Hauck S . Met/HGFR triggers detrimental reactive microglia in TBI. Cell Rep. 2022; 41(13):111867. DOI: 10.1016/j.celrep.2022.111867. View